Amarin (AMRN) highlighted recently published data in the Journal of the American Heart Association showing in a post-hoc analysis of the ...

Austrian Health Authorities Approve VAZKEPA® (icosapent ethyl) for National Reimbursement to Reduce Risk of Cardiovascular Events in Eligible ...

DUBLIN, Ireland and BRIDGEWATER, N.J., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), today announced that Austria’s Health Authorities have approved VAZKEPA® for ...

NASHVILLE, Tenn., Feb. 25, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that it will release its annual 2024 financial ...

Amarin Co. plc (NASDAQ:AMRN – Free Report) – Investment analysts at Zacks Research lowered their FY2025 earnings estimates for Amarin in a research note issued on Tuesday, February 11th.

To make the world smarter, happier, and richer. Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches ...

Learn more about whether Alnylam Pharmaceuticals, Inc. or BioMarin Pharmaceutical Inc. is a better investment based on AAII's ...

Indian drugmakers earn a significant share of revenue from the U.S., the largest importer of Indian pharma products. India's pharma exports to the country stood at $8.73 billion in fiscal 2024 - a ...

We believe that the need for pharma companies to replenish their medium-term product pipelines with innovative assets makes NOX-A12 an attractive opportunity for potential partners looking to ...

HERZLIYA, Israel and CALGARY, AB, Feb. 18, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in ...

Innovative Chronic Pain Treatment Receives IP Protection in India's $55 Billion Pharmaceutical Market HERZLIYA, Israel and CALGARY, AB, Feb. 18, 2025 /PRNewswire/ -- Innocan Pharma Corporation ...